Met and Cxcr4 cooperate to protect skeletal muscle stem cells against inflammation-induced damage during regeneration

  1. Ines Lahmann
  2. Joscha Griger
  3. Jie-Shin Chen
  4. Yao Zhang
  5. Markus Schülke
  6. Carmen Birchmeier-Kohler  Is a corresponding author
  1. Max Delbrück Center for Molecular Medicine in the Helmholtz Society, Germany
  2. Max Delbrueck Center for Molecular Medicine (MDC) in the Helmholtz Society, Germany
  3. Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, Germany

Abstract

Acute skeletal muscle injury is followed by an inflammatory response, removal of damaged tissue, and the generation of new muscle fibers by resident muscle stem cells, a process well characterized in murine injury models. Inflammatory cells are needed to remove the debris at the site of injury and provide signals that are beneficial for repair. However, they also release chemokines, reactive oxygen species as well as enzymes for clearance of damaged cells and fibers, which muscle stem cells have to withstand in order to regenerate the muscle. We show here that MET and CXCR4 cooperate to protect muscle stem cells against the adverse environment encountered during muscle repair. This powerful cyto-protective role was revealed by the genetic ablation of Met and Cxcr4 in muscle stem cells of mice, which resulted in severe apoptosis during early stages of regeneration. TNFα neutralizing antibodies rescued the apoptosis, indicating that TNFα provides crucial cell-death signals during muscle repair that are counteracted by MET and CXCR4. We conclude that muscle stem cells require MET and CXCR4 to protect them against the harsh inflammatory environment encountered in an acute muscle injury.

Data availability

Data are available in the Article, Supplementary Information or from the corresponding authors (CB) upon reasonable request. Source data are provided with this paper.

Article and author information

Author details

  1. Ines Lahmann

    Developmental Biology/Signal Transduction Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Society, Berlin, Germany
    Competing interests
    No competing interests declared.
  2. Joscha Griger

    Developmental Biology/Signal Transduction Group, Max Delbrueck Center for Molecular Medicine (MDC) in the Helmholtz Society, Berlin, Germany
    Competing interests
    No competing interests declared.
  3. Jie-Shin Chen

    Developmental Biology/Signal Transduction Group, Max Delbrueck Center for Molecular Medicine (MDC) in the Helmholtz Society, Berlin, Germany
    Competing interests
    Jie-Shin Chen, Jie-Shin Chen is now affiliated with AstraZeneca; all work for this manuscript was conducted while affiliated with Max Delbrueck Center for Molecular Medicine (MDC) in the Helmholtz Society.
  4. Yao Zhang

    Developmental Biology/Signal Transduction Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Society, Berlin, Germany
    Competing interests
    No competing interests declared.
  5. Markus Schülke

    Department of Neuropediatrics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, Berlin, Germany
    Competing interests
    No competing interests declared.
  6. Carmen Birchmeier-Kohler

    Developmental Biology/Signal Transduction Group, Max Delbrueck Center for Molecular Medicine (MDC) in the Helmholtz Society, Berlin, Germany
    For correspondence
    cbirch@mdc-berlin.de
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2041-8872

Funding

Deutsche Forschungsgemeinschaft

  • Carmen Birchmeier-Kohler

AFM

  • Carmen Birchmeier-Kohler

Klinische Forschergruppe KFO 192

  • Carmen Birchmeier-Kohler

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Gabrielle Kardon, University of Utah, United States

Ethics

Animal experimentation: All experiments were conducted according to regulations established by the Max-Delbrück- Center for Molecular Medicine (MDC) and the Landesamt für Gesundheit und Soziales (0320/10; 0130/13).

Version history

  1. Received: March 29, 2020
  2. Accepted: August 4, 2021
  3. Accepted Manuscript published: August 5, 2021 (version 1)
  4. Version of Record published: August 17, 2021 (version 2)
  5. Version of Record updated: August 18, 2021 (version 3)

Copyright

© 2021, Lahmann et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,374
    views
  • 218
    downloads
  • 8
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ines Lahmann
  2. Joscha Griger
  3. Jie-Shin Chen
  4. Yao Zhang
  5. Markus Schülke
  6. Carmen Birchmeier-Kohler
(2021)
Met and Cxcr4 cooperate to protect skeletal muscle stem cells against inflammation-induced damage during regeneration
eLife 10:e57356.
https://doi.org/10.7554/eLife.57356

Share this article

https://doi.org/10.7554/eLife.57356

Further reading

    1. Developmental Biology
    Zhimin Xu, Zhao Wang ... Yingchuan B Qi
    Research Article

    Precise developmental timing control is essential for organism formation and function, but its mechanisms are unclear. In C. elegans, the microRNA lin-4 critically regulates developmental timing by post-transcriptionally downregulating the larval-stage-fate controller LIN-14. However, the mechanisms triggering the activation of lin-4 expression toward the end of the first larval stage remain unknown. We demonstrate that the transmembrane transcription factor MYRF-1 is necessary for lin-4 activation. MYRF-1 is initially localized on the cell membrane, and its increased cleavage and nuclear accumulation coincide with lin-4 expression timing. MYRF-1 regulates lin-4 expression cell-autonomously and hyperactive MYRF-1 can prematurely drive lin-4 expression in embryos and young first-stage larvae. The tandem lin-4 promoter DNA recruits MYRF-1GFP to form visible loci in the nucleus, suggesting that MYRF-1 directly binds to the lin-4 promoter. Our findings identify a crucial link in understanding developmental timing regulation and establish MYRF-1 as a key regulator of lin-4 expression.

    1. Developmental Biology
    2. Structural Biology and Molecular Biophysics
    Samuel C Griffiths, Jia Tan ... Hsin-Yi Henry Ho
    Research Article Updated

    The receptor tyrosine kinase ROR2 mediates noncanonical WNT5A signaling to orchestrate tissue morphogenetic processes, and dysfunction of the pathway causes Robinow syndrome, brachydactyly B, and metastatic diseases. The domain(s) and mechanisms required for ROR2 function, however, remain unclear. We solved the crystal structure of the extracellular cysteine-rich (CRD) and Kringle (Kr) domains of ROR2 and found that, unlike other CRDs, the ROR2 CRD lacks the signature hydrophobic pocket that binds lipids/lipid-modified proteins, such as WNTs, suggesting a novel mechanism of ligand reception. Functionally, we showed that the ROR2 CRD, but not other domains, is required and minimally sufficient to promote WNT5A signaling, and Robinow mutations in the CRD and the adjacent Kr impair ROR2 secretion and function. Moreover, using function-activating and -perturbing antibodies against the Frizzled (FZ) family of WNT receptors, we demonstrate the involvement of FZ in WNT5A-ROR signaling. Thus, ROR2 acts via its CRD to potentiate the function of a receptor super-complex that includes FZ to transduce WNT5A signals.